Our pharmaceutical network and knowledge gives us a significant advantage in the Cannabis space of drug development and due diligence

Our Cannabis drug development experts have supported the largest marquee transactions in the cannabis space. Our experts advise companies in areas of biosynthesis and synthetic chemistry,  plant genetics and cultivation, formulation and drug delivery, intellectual property development, facility audits and licensing. Our quality team conducts one audit per week (over 50 per year).

"We've worked with Novateur on a number of scientific due diligence mandates and have been consistently impressed with their diligence capabilities, professional behavior and work ethics, level of service, can-do attitude, and quality of insights. Novateur has exceeded my expectations as an engagement partner." 

Rami El-Cheikh, MBA, CMA, PMP
Partner, PwC